These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11686002)

  • 41. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation.
    Naderi GA; Asgary S; Sarraf-Zadegan N; Shirvany H
    Mol Cell Biochem; 2003 Apr; 246(1-2):193-6. PubMed ID: 12841362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxidative stress mediates apoptosis induced by oxidized low-density lipoprotein and oxidized lipoprotein(a).
    Heermeier K; Schneider R; Heinloth A; Wanner C; Dimmeler S; Galle J
    Kidney Int; 1999 Oct; 56(4):1310-2. PubMed ID: 10504482
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bis(monoacylglycero)phosphate reduces oxysterol formation and apoptosis in macrophages exposed to oxidized LDL.
    Arnal-Levron M; Chen Y; Delton-Vandenbroucke I; Luquain-Costaz C
    Biochem Pharmacol; 2013 Jul; 86(1):115-21. PubMed ID: 23542536
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells.
    Napoli C; Quehenberger O; De Nigris F; Abete P; Glass CK; Palinski W
    FASEB J; 2000 Oct; 14(13):1996-2007. PubMed ID: 11023984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology of atherosclerosis.
    Chobanian AV
    Am J Cardiol; 1992 Nov; 70(17):3G-7G. PubMed ID: 1449096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophages, endothelial cells, and lipoprotein oxidation in the pathogenesis of atherosclerosis.
    Rosenfeld ME; Palinski W; Ylä-Herttuala S; Carew TE
    Toxicol Pathol; 1990; 18(4 Pt 1):560-71. PubMed ID: 2091235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status.
    Orem C; Orem A; Uydu HA; Celik S; Erdöl C; Kural BV
    Coron Artery Dis; 2002 Feb; 13(1):65-71. PubMed ID: 11917201
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-oxidative modification of native low-density lipoprotein by oxidized low-density lipoprotein.
    Yang M; Leake DS; Rice-Evans CA
    Biochem J; 1996 Jun; 316 ( Pt 2)(Pt 2):377-80. PubMed ID: 8687375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oxidized low density lipoprotein potentiation of Fas-induced apoptosis through lectin-like oxidized-low density lipoprotein receptor-1 in human umbilical vascular endothelial cells.
    Imanishi T; Hano T; Sawamura T; Takarada S; Nishio I
    Circ J; 2002 Nov; 66(11):1060-4. PubMed ID: 12419941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids.
    Navab M; Berliner JA; Subbanagounder G; Hama S; Lusis AJ; Castellani LW; Reddy S; Shih D; Shi W; Watson AD; Van Lenten BJ; Vora D; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):481-8. PubMed ID: 11304461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Low-density lipoprotein and oxidised low-density lipoprotein: their role in the development of atherosclerosis.
    Hamilton CA
    Pharmacol Ther; 1997; 74(1):55-72. PubMed ID: 9336016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines.
    Nègre-Salvayre A; Salvayre R
    Free Radic Biol Med; 1992; 12(2):101-6. PubMed ID: 1559614
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxidation of LDL, atherogenesis, and apoptosis.
    Napoli C
    Ann N Y Acad Sci; 2003 Dec; 1010():698-709. PubMed ID: 15033814
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New pathogenetic hypothesis for Wolman disease: possible role of oxidized low-density lipoproteins in adrenal necrosis and calcification.
    Fitoussi G; Nègre-Salvayre A; Pieraggi MT; Salvayre R
    Biochem J; 1994 Jul; 301 ( Pt 1)(Pt 1):267-73. PubMed ID: 8037680
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo oxidized low density lipoprotein: degree of lipoprotein oxidation does not correlate with its atherogenic properties.
    Tertov VV; Kaplun VV; Orekhov AN
    Mol Cell Biochem; 1998 Jun; 183(1-2):141-6. PubMed ID: 9655188
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physiological aspects of low-density lipoprotein oxidation.
    Thomas MJ
    Curr Opin Lipidol; 2000 Jun; 11(3):297-301. PubMed ID: 10882346
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aged garlic extract and its constituents inhibit Cu(2+)-induced oxidative modification of low density lipoprotein.
    Ide N; Nelson AB; Lau BH
    Planta Med; 1997 Jun; 63(3):263-4. PubMed ID: 9225610
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sphingolipids in atherosclerosis and vascular biology.
    Chatterjee S
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential inhibition of oxidized LDL-induced apoptosis in human endothelial cells treated with different flavonoids.
    Jeong YJ; Choi YJ; Kwon HM; Kang SW; Park HS; Lee M; Kang YH
    Br J Nutr; 2005 May; 93(5):581-91. PubMed ID: 15975156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.